Specifically, BRCA1 expression is reduced in the brains of patients with Alzheimer’s disease (AD), as well as in the brain of an AD mouse model expressing human amyloid-β precursor43. Here, BRCA1 is linked to early-onset autosomal dominant Alzheimer disease.